Reversible myelosuppression suspected to be secondary to linezolid in a cat with infected subcutaneous ureteral bypass systems
Case summary A 5-year-old castrated male domestic shorthair cat was presented for a multidrug-resistant Enterococcus faecium urinary tract infection within its bilateral subcutaneous ureteral bypass systems. After considerable consultation, the cat was treated with oral linezolid (10 mg/kg q12h) for...
Main Authors: | Barry A Hedgespeth, Karen M Tefft, Allison R Kendall |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-11-01
|
Series: | Journal of Feline Medicine and Surgery Open Reports |
Online Access: | https://doi.org/10.1177/2055116920967226 |
Similar Items
-
Subcutaneous ureteral bypass for treatment of proximal ureteral obstruction secondary to retroperitoneal fibrosis after renal transplantation in a cat
by: Peter J Laminette, et al.
Published: (2024-08-01) -
Risk factors for positive urine cultures in cats with subcutaneous ureteral bypass and ureteral stents (2010‐2016)
by: Lucy Kopecny, et al.
Published: (2019-01-01) -
Surgical repositioning with omentalisation of an exposed subcutaneous ureteral bypass shunting port in a cat
by: Shi Min Lee, et al.
Published: (2024-06-01) -
Risk factors and clinical relevance of positive urine cultures in cats with subcutaneous ureteral bypass
by: Julie Deprey, et al.
Published: (2021-05-01) -
Use of a subcutaneous ureteral bypass device for treatment of bilateral proximal ureteral injury in a 9-month-old cat
by: Joseph A Sapora, et al.
Published: (2019-03-01)